The percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market is estimated to be valued at USD 2.84 Bn in 2025 and is expected to reach USD 5.48 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.
To learn more about this report, Request sample copy
The increasing incidence of cardiac conditions such as acute myocardial infarction and angina is the primary factor driving the growth of the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market. Additionally, growing preference for minimally invasive procedures over traditional surgery due to advantages such as lesser recovery time, minimal pain, and scarring are also expected to propel the demand for PTCA balloon catheters. However, risks and complications associated with PTCA procedures along with availability of alternative treatment methods such as stents may hamper revenue generation.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients